Enhanced Recovery Program for Children of Western Rajasthan undergoing stomach and Intestinal Surgery

Impact of region specific enhanced recovery after surgery protocol on the systemic inflammatory response in paediatric Gastrointestinal Surgery in Western Rajasthan: A prospective randomised controlled trial - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/110327

Enrollment

Registered

2026-05-11

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K918- Other intraoperative and postprocedural complications and disorders of digestive system Health Condition 2: K318- Other specified diseases of stomach and duodenum

Interventions

Intervention1: Group I [ERAS]: Patients will be given treatment with the Region specific Enhanced Recovery after Surgery (ERAS) Protocol Control Intervention1: Group II [Control]: Patients will be giv

Eligibility

Inclusion criteria

Inclusion criteria: Paediatric patients in the age group between 1 month -18 years of either sex, belonging to ASA grade 1 or 2, scheduled for elective major gastrointestinal surgeries of duration more than 2 hours will be included after written informed consent or assent

Exclusion criteria

Exclusion criteria: 1. Patients with congenital heart disease or uncontrolled systemic illness 2. Patients with associated syndromes 3. Patients who are intubated preoperatively 4. Patients requiring postoperative ventilation support Patient with BMI more than 35 kg/m2

Design outcomes

Primary

Measure	Time frame
To compare change in the level of IL-6 in blood from baseline in ERAS group vs standard care group.Timepoint: Post operative day 1.	—

Secondary

Measure	Time frame
To compare change in the level of CRP, PCT in blood from baseline in both the groups Timepoint: Post operative day 1;To compare change in the level of IL-6, CRP, PCT in blood from baseline in both the groups Timepoint: Post operative day 3;To compare the value of IL-6, CRP, PCT in blood. Timepoint: Post operative day 1 and 3;To compare clinical outcomes: time to first oral intake, time to mobilization, length of hospital stay and hospital re-admission rate Timepoint: Post operative day;To compare postoperative complications like post-operative nausea and vomiting, postoperative pain, emergence delirium, fluid and electrolyte abnormalitiesTimepoint: Post operative day	—

Measure

Time frame

To compare change in the level of CRP, PCT in blood from baseline in both the groups Timepoint: Post operative day 1;To compare change in the level of IL-6, CRP, PCT in blood from baseline in both the groups Timepoint: Post operative day 3;To compare the value of IL-6, CRP, PCT in blood. Timepoint: Post operative day 1 and 3;To compare clinical outcomes: time to first oral intake, time to mobilization, length of hospital stay and hospital re-admission rate Timepoint: Post operative day;To compare postoperative complications like post-operative nausea and vomiting, postoperative pain, emergence delirium, fluid and electrolyte abnormalitiesTimepoint: Post operative day

—

Countries

India

Contacts

Public ContactDr Kamlesh Kumari

All India Institute of Medical Sciences Jodhpur

kumarik@aiimsjodhpur.edu.in9780040150

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026